UK announces £48 million dementia research partnership
The government says the funding will support a UK-wide alliance focused on improving recruitment to clinical trials and speeding development of treatments.
https://davids.news/s/uk-announces-48-million-dementia-research-partnership-6bb4bfca
- The government says it will invest £33 million through the Dame Barbara Windsor Dementia Goals programme.
- Bristol Myers Squibb, GSK and Gates Ventures are also contributing, according to the announcement.
The partnership aims to address difficulties recruiting participants for dementia studies, the government says.
A little more context
The UK Government announced a £48 million partnership involving government, industry, academia, charities and people with lived experience of dementia. It says the BARBARA Alliance will work to make it easier for people to join clinical trials and support development of new treatments. The announcement identifies recruitment to clinical studies as a barrier to dementia research.
Listen to this brief~30 sec
Go straight to the source
Every factual claim links back to the reporting. We summarize in our own words.
The story’s history
- Version 1 · 2 hr ago
First verified brief published.
How this brief is grounded
UK announces £48 million dementia research partnershipUK Government
The government says the funding will support a UK-wide alliance focused on improving recruitment to clinical trials and speeding development of treatments.UK Government
The government says it will invest £33 million through the Dame Barbara Windsor Dementia Goals programme.UK Government
Bristol Myers Squibb, GSK and Gates Ventures are also contributing, according to the announcement.UK Government
The partnership aims to address difficulties recruiting participants for dementia studies, the government says.UK Government
The UK Government announced a £48 million partnership involving government, industry, academia, charities and people with lived experience of dementia.UK Government
It says the BARBARA Alliance will work to make it easier for people to join clinical trials and support development of new treatments.UK Government
The announcement identifies recruitment to clinical studies as a barrier to dementia research.UK Government